Clinical Trial Update: Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of docetaxel, thalidomide, prednisone, and bevacizumab for metastatic prostate cancer; the study is completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)
• Docetaxel (Taxotere) (docetaxel)
• PREDNISONE (Prednisone)
• Thalidomide (thalidomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostatic Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2012-11-14